nav.banner_textnav.banner_cta →
SwissNova Labs
Cagrilintide research vial
SwissNova Labs
Cagrilintide · 5mg
≥99% Purity · COA Included
Metabolic

Cagrilintide

Purity: 99%+
Size: 5mg
Grade: Research
Form: Lyophilized
✦
SwissNova Labs · Research Grade
Back to catalog
MetabolicNEW!

Cagrilintide

Long-acting amylin analog for appetite suppression and weight management.

Appetite suppression — central amylin receptor activation reduces food intakeLong half-life — ~7 days enables once-weekly dosingSynergistic with GLP-1 — CagriSema combination shows 25% weight lossCardiometabolic improvement — reduces cardiovascular risk markers
$90.00
5mg · Research use only
Compound Specifications
Purity99%+
Molecular Weight~4000 Da
Vial Size5mg
SequenceLong-acting amylin analog (fatty acid modified)
Dosage Reference
Range0.3–2.4 mg
FrequencyOnce weekly
RouteSubcutaneous injection
Half-life~7 days
Vial Supply
Duration~5 weeks supply
Week 1Week 5

1 mg/week

Why Researchers Choose This Compound

Key Benefits

01
Appetite suppression

central amylin receptor activation reduces food intake

02
Long half-life

~7 days enables once-weekly dosing

03
Synergistic with GLP-1

CagriSema combination shows 25% weight loss

04
Cardiometabolic improvement

reduces cardiovascular risk markers

Administration Guide

Recommended Injection Sites

Optimal injection locations for Cagrilintide based on its route (Subcutaneous injection) and pharmacokinetic profile.

Tap a glowing zone on the body map to highlight the matching site card — or tap a card to activate the zone.

Site Map — front

Tap a zone to inject

Best
Good
Acceptable
Primary Sites
Abdomen
Best
Periumbilical fat

Preferred for weekly injections.

Thigh
Good
Anterolateral mid-thigh

Good alternative.

Secondary Sites
Deltoid
Acceptable
Lateral shoulder fat

Use if other sites unavailable.

Needle Specs
Gauge27–29 gauge
Length5/16" – 1/2"
Angle45–90°
Site Rotation

Rotate weekly injection sites.

Avoid
  • IV administration
  • Intramuscular injection
Mechanism of Action

Active Signaling Pathway

Synergistic Protocols

Recommended Stacks

Cagrilintide is a key compound in these curated research stacks. Pair it with synergistic peptides for enhanced outcomes.

Fitness & Performance

Metabolic Reset Protocol

Next-generation GLP-1 + amylin combination for advanced weight management research.

NEW!
Cagrilintide — Secondary — Amylin receptor agonist
Adds complementary satiety signaling via amylin receptors. CagriSema combination shows up to 25% weight loss — exceeding either agent alone.
20–52 weeksAdvanced3 compounds
View Full Stack →
Supply Calculator

How long will one vial last?

Based on standard research protocols, here's exactly what to expect from a single 5mg vial — and when to plan your next order.

One vial lasts
5
weeks
That's approximately 1 month of continuous use at the standard protocol dose.
Reorder around week 4 to avoid running out
Your supply timeline5mg vial
Start↑ ReorderWeek 5 — empty
1
2
3
4
5
Active supplyReorder week
How we calculated this
5mg vial ÷ 1 mg/week = 5 weeks of supply

Actual duration may vary based on your specific protocol. Always consult your research guidelines for precise dosing schedules.

Research Literature

Scientific Background

Mechanism of Action

Cagrilintide binds amylin receptors (AMY1–3) in the area postrema and hypothalamus, reducing food intake via central satiety signaling. Its fatty acid modification enables albumin binding, extending half-life to ~7 days. Combined with GLP-1 agonists, it provides complementary and synergistic appetite suppression.

Clinical Context

Cagrilintide is currently in Phase 3 trials as part of the CagriSema combination. It represents the next generation of weight management research beyond GLP-1 monotherapy.

Research Highlights

  • Phase 2 trials showed 15.6% weight loss as monotherapy over 26 weeks
  • CagriSema combination demonstrated up to 25% weight reduction — exceeding either agent alone
  • Half-life of ~7 days enables once-weekly dosing
  • Demonstrated improvements in cardiometabolic risk markers in obese subjects

Storage & Reconstitution

Store at -20°C. Reconstitute with 1 mL bacteriostatic water → 5 mg/mL. Stable 28 days at 2–8°C. Protect from light.

PROTOCOL NOTE

Titrate dose over 16 weeks. Can be combined with semaglutide for synergistic effect.

RESEARCH USE ONLY:All products are sold strictly for in vitro research and laboratory use. Not intended for human consumption, clinical use, diagnosis, treatment, or prevention of any disease or condition. By purchasing, you confirm you are a qualified researcher and will use these compounds in accordance with all applicable laws and regulations.